Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 18,433-18,444 of 23,847
Drug study icon
CompletedNCT00678730

Pharmacogenetics of Cannabinoid Response

This summary needs review. Please check the official study record and contact the research team for details.

In West Haven
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Drug study icon
CompletedNCT03226223

Pharmacogenetics of Naltrexone for Stimulant Abuse

This summary needs review. Please check the official study record and contact the research team for details.

In New York
AddictionDrugFrom 21 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Addiction
Drug study icon
CompletedNCT01314001

Pharmacogenetics of Nicotine Addiction Treatment

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Buffalo
AddictionDrugFrom 18 Years to 65 Years
Countries
United States, Canada
Sponsor
University of Pennsylvania
Condition
Addiction
Drug study icon
CompletedNCT00507728

Pharmacogenetics, Emotional Reactivity and Smoking

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
M.D. Anderson Cancer Center
Condition
Addiction
Behavioral study icon
CompletedNCT03674138

Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

In Tampa
Depression, AnxietyBehavioralOver 18 Years
Countries
United States
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Condition
Depression, Anxiety
Other study type icon
TerminatedNCT03730870

Pharmacogenomics for Improving Pediatric ADHD Treatment

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Hamilton
ADHDDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 6 Years to 18 Years
Countries
United States
Sponsor
Clinical and Translational Genome Research Institute, Inc.
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.